Why Core Scientific, Inc.’s (CORZ) Stock Is Up 21.88%
As of Thursday, July 30, Core Scientific, Inc.’s CORZ share price has surged by 21.88%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Michael Rose
Jenna Brashear
Michael Rose
| Share Statistics | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,658.2 | $977.4 | 72% |
|
| Shares Out (Mil) | 325.3 | 78.1 | 84% |
|
| Institutional Ownership | 98.2% | 79.0% | 78% |
|
| Float (Mil) | 259.0 | 57.6 | 78% |
|
| Beta | 5.49 | 1.03 | 100% |
|
| Avg Daily Volume (000s) | 15,346 | 750 | 98% |
|
| Price Change (52-week) |
58.7% | 56.5% | 83% |
|
| Growth | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 39.5% | 14.8% | 93% |
|
| Net Income (5yr) | (88.3%) | 10.1% | 2% |
|
| EPS (5yr) | (43.7%) | 16.2% | 4 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (178.3%) | (15.3%) | 0% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 2 | |
| Current EPS | ($0.030) | ($4.660) | $0.185 | |
| Month Ago EPS | ($0.055) | ($1.040) | $0.297 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | $0.000 | ($0.055) | $0.420 | |
| Year/Year Chg | (99.1%) | 427.7% | (143.0%) | |
| Financials | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $440 | $348 | 40% |
|
| Net Income (TTM) (Mil) | ($1,431) | ($2) | 1% |
|
| EPS (TTM) | ($5.073) | ($0.100) | 8% |
|
| Operating Cash Flow (TTM) (Mil) | $520 | $30 | 72% |
|
| Net Cash Flow (TTM) (Mil) | $1,970 | $0 | 97% |
|
| Long-Term Debt (Q1) (Mil) | $4,394 | $35 | 84% |
|
| Enterprise Value (Q1) (Mil) | $9,304 | $1,019 | 73% |
|
| Valuation | CORZ | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.24 | na |
|
| P/E | na | 34.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.1 | na |
|
| Ratios | CORZ | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 32.1% | 70.5% | 38% |
|
| Net Margin | (324.9%) | 0.6% | 3% |
|
| ROA | (39.5%) | (1.6%) | 14% |
|
| ROE | 82.1% | 1.6% | 95% |
|
| Liabilities to Assets | 146.0% | 46.1% | 98% |
|
| F-Score | 4 | 5 | 34% |
|
Core Scientific, Inc. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors